Index by author

March 01, 2025; Volume 92,Issue 3

  1. Bakaeen, Faisal G.

    1. Coronary artery bypass grafting: Practice trends and projections
      Coronary artery bypass grafting: Practice trends and projections
      Richard Ramsingh, MD and Faisal G. Bakaeen, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 181-191; DOI: https://doi.org/10.3949/ccjm.92a.23071

      Future directions include expanding the use of multiarterial grafting, offering patients less-invasive approaches, and enhancing operative recovery.

  2. Barnett, Brian S.

    1. Psychedelic-assisted therapy: An overview for the internist
      Brian S. Barnett, MD, Erin E. Mauney, MD and Franklin King, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 171-180; DOI: https://doi.org/10.3949/ccjm.92a.24032

      The authors review the potential effects, risks, and therapeutic applications of the psychedelic drugs MDMA (Ecstasy) and psilocybin, with a focus on MDMA-assisted therapy for posttraumatic stress disorder and psilocybin-assisted therapy for depression.

  3. Budhiraja, Pooja

    1. Effective but inaccessible antiobesity medications
      Sima Saberi, MD, Sabiha M. Hussain, MD, Mohammad Kazem Fallahzadeh, MD, MAS, Hector Madariaga, MD, Pooja Budhiraja, MBBS and Kenneth J. Woodside, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 141; DOI: https://doi.org/10.3949/ccjm.92c.03001

  4. Chaplain, Margaret M.

    1. In Reply: Insomnia in older adults
      Margaret M. Chaplain, MD, Roberto León-Barriera, MD and Vania Modesto-Lowe, MD, MPH
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 144; DOI: https://doi.org/10.3949/ccjm.92c.03005

  5. Cline, Nicholas B.

    1. Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
      Nicholas B. Cline, MD, Amudha Pazhanisamy, DO and David M. Lang, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 147-151; DOI: https://doi.org/10.3949/ccjm.92a.24054

      There is no cross-reactivity between antimicrobial and nonantimicrobial sulfonamides, and patients with a history of immunoglobulin E–mediated reaction to a sulfonamide antibiotic can receive nonantimicrobial sulfonamides.

  6. Fallahzadeh, Mohammad Kazem

    1. Effective but inaccessible antiobesity medications
      Sima Saberi, MD, Sabiha M. Hussain, MD, Mohammad Kazem Fallahzadeh, MD, MAS, Hector Madariaga, MD, Pooja Budhiraja, MBBS and Kenneth J. Woodside, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 141; DOI: https://doi.org/10.3949/ccjm.92c.03001

  7. Ghandakly, Elizabeth

    1. Cardiovascular disease in people living with HIV: Risk assessment and management
      Elizabeth Ghandakly, MD, JD, Rohit Moudgil, MD, PhD and Katherine Holman, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 159-167; DOI: https://doi.org/10.3949/ccjm.92a.24055

      Because people living with HIV develop coronary artery disease much earlier than the general population, careful attention must be given to assessment and management of their cardiovascular risk.

  8. Hekman, James

    1. Heart to heart: Progress in cardiovascular disease prevention for people living with HIV
      James Hekman, MD and Henry H. Ng, MD, MPH
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 168-170; DOI: https://doi.org/10.3949/ccjm.92a.24126

      The already higher cardiovascular risk in people living with HIV is exacerbated by social determinants of health such as socioeconomic status, access to healthcare, and systemic discrimination. Interventions that address this risk must be based in medical science and equity.

  9. Holman, Katherine

    1. Cardiovascular disease in people living with HIV: Risk assessment and management
      Elizabeth Ghandakly, MD, JD, Rohit Moudgil, MD, PhD and Katherine Holman, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 159-167; DOI: https://doi.org/10.3949/ccjm.92a.24055

      Because people living with HIV develop coronary artery disease much earlier than the general population, careful attention must be given to assessment and management of their cardiovascular risk.

  10. Hussain, Sabiha M.

    1. Effective but inaccessible antiobesity medications
      Sima Saberi, MD, Sabiha M. Hussain, MD, Mohammad Kazem Fallahzadeh, MD, MAS, Hector Madariaga, MD, Pooja Budhiraja, MBBS and Kenneth J. Woodside, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 141; DOI: https://doi.org/10.3949/ccjm.92c.03001
« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue